Dexmedetomidine-esketamine combination

DRUG6 trials

Sponsors

Peking University First Hospital

Conditions

AdultsAgedCognitive ImpairmentDeliriumDexmedetomidineEsketamineIntensive Care UnitIntensive Care Units

Phase 4

Mini-dose Dexmedetomidine-Esketamine Supplemented Analgesia in Patients at High-risk of OSA

CompletedNCT06566482

Peking University First HospitalDexmedetomidine, Esketamine, Obstructive Sleep Apnea +2

Start: 2024-09-11End: 2025-08-30Updated: 2026-09-04

Dexmedetomidine-Esketamine Combination and Sleep Disturbances After Major Noncardiac Surgery

RecruitingNCT06859892

Peking University First HospitalAdults, Dexmedetomidine, Esketamine +2

Start: 2025-03-18End: 2026-12-31Target: 476Updated: 2025-03-19

Sedation With Dexmedetomidine-esketamine Combination and Delirium in ICU Patients

CompletedNCT07151716

Peking University First HospitalDelirium, Dexmedetomidine, Esketamine +3

Start: 2025-10-21End: 2026-04-24Updated: 2026-06-30

Intranasal Dexmedetomidine-esketamine on Sleep and Cognition in Older Adults With Mild-to-moderate Cognitive Impairment

Not yet recruitingNCT07610343

Peking University First HospitalCognitive Impairment, Dexmedetomidine, Esketamine +2

Start: 2026-06-01End: 2027-12-01Target: 60Updated: 2026-06-01

Unknown Phase

Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation

CompletedNCT06003218

Peking University First HospitalDexmedetomidine, Esketamine, Liver Cancer +1

Start: 2023-10-16End: 2024-09-28Updated: 2025-04-02

Dexmedetomidine-Esketamine Combination for Sedation and Analgesia in ICU Patients

Not yet recruitingNCT06468436

Peking University First HospitalAged, Delirium, Dexmedetomidine +3

Start: 2025-11-30End: 2030-12-01Target: 1508Updated: 2025-07-31